Showing results (271-280 of 675) with videos related to
Sort By:
Pageof 68
Journal of Genetic Counseling|November 16, 2006
Ethical issues in cancer genetics: I 1) whose information is it?Katherine A Schneider, Anu B Chittenden, Kelly J Branda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2022
Regulation of Laboratory-Developed Tests in Preventive Oncology: Emerging Needs and OpportunitiesKenneth Offit, Catherine M Sharkey, Dina Green, et al.JAMA Oncology|July 2, 2016
Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA MutationsCatherine A Shu, Malcolm C Pike, Anjali R Jotwani, et al.European Urology Oncology|April 5, 2025
Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle FactorsZhizhu Zhang, Yiwen Zhang, Konrad H Stopsack, et al.Breast Cancer Research : BCR|February 13, 2010
Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic featuresNadine Tung, Yihong Wang, Laura C Collins, et al.Medrxiv : the Preprint Server for Health Sciences|September 15, 2025
Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical OutcomesMona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger, et al.Cancer Discovery|June 17, 2018
Precision Prevention and Early Detection of Cancer: Fundamental PrinciplesTimothy R Rebbeck, Karen Burns-White, Andrew T Chan, et al.The Journal of Clinical Investigation|June 9, 2026
Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomesMona Arabzadeh, Yi-Han Tang, Christelle Colin-Leitzinger, et al.Clinical Genitourinary Cancer|September 20, 2022
Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition SyndromesMatthew Mossanen, Amin H Nassar, Samantha M Stokes, et al.Frontiers in Oncology|September 12, 2022
An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genesAlison Schwartz, Danielle K Manning, Diane R Koeller, et al.Pageof 68